CXCL11 and Parkinson disease: Furthermore, TRIP-Br1 is induced in neurons following nerve growth factor deprivation and β-amyloid treatment and is required for neuronal cell death (Biswas et al., 2010), and TRIP-Br1 expression is also elevated in a cellular model of Parkinson’s disease (Ryu et al., 2005) and in cancer cells (Hong et al., 2009).